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Advances in knowledge: 
1. Advanced computational methods using multiparametric deep learning (MPDL) with multiparametric MRI are 
significant predictors of malignant or benign breast lesions. 
 
2. Development of a “tissue based” deep learning method validated with an independent radiological data set. 
 
 
3. The MPDL model with pharmacokinetic modeling parameters and diffusion weighted imaging/Apparent 
Diffusion Coefficient metrics demonstrated similar diagnostic performance of the radiologist in characterizing 
breast lesions. 
  
Implications for patient care: The integration of advanced computational techniques and artificial 
intelligence methods to assist radiologists will become available in the future reading rooms and will 
transform medicine in general. Deep learning methods will be the conduit for modeling of clinical and 
radiological variables which will provide the foundation for radiological precision medicine in patients. 
 
Abstract 
Background and Purpose: Integration of advanced computational techniques and artificial intelligence 
methods to assist radiologists will become available in future reading rooms and will transform medicine 
in general. This study was conducted to evaluate the feasibility and role of a novel deep learning method 
using multiparametric breast Magnetic Resonance Imaging(mpMRI) and defining tissue signatures for 
improved automated detection and characterization of breast lesions. 
Methods: We developed and tested a multiparametric deep learning(MPDL) network for segmentation 
and classification of breast MRI in 171 patients. The MPDL network was constructed from stacked 
sparse autoencoders. MPDL network inputs were T1 and T2-weighted imaging, diffusion weighted 
imaging(DWI) and ADC mapping, and dynamic contrast enhanced(DCE) imaging tissue signatures.  
Evaluation of MPDL consisted of cross-validation, sensitivity and specificity. Dice similarity between 
MPDL and post-DCE lesions were evaluated. Statistical significance was set at p≤0.05. 
Results: The performance of MPDL on Modified National Institute of Standards and Technology 
database(MISNT) data set was 99.7%. For MRI validation set, a 4.2%±3.6% percent difference 
between volumes was found between MPDL and test data set.  The MPDL segmented glandular, fatty, 
and lesion tissue with an overlap of 0.87±0.05 for malignant patients and 0.85±0.07 for benign patients.  
The sensitivity and specificity for differentiation of malignant from benign lesions were 90% and 85% 
respectively with an AUC of 0.93   
Conclusion: Integrated MPDL method accurately segmented and classified different breast tissue from 
multiparametric breast MRI.  Deep learning can be used to construct a personalized database of tissue 
signatures with accurate characterization of different tissue types. 
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Introduction 
A new paradigm is beginning to emerge in Radiology with the advent of increased computational 
capabilities and algorithms.  This has led to the ability of “real time” learning by computer systems of 
different lesion types to help the radiologist in defining disease.  In particular using deep learning 
algorithms to segment and classify different radiological images.   We chose to use multiparametric 
magnetic resonance imaging (mpMRI) parameters which capitalize on the different contrasts of tissue.  
For example, using conventional and advanced MRI parameters of T1- and T2-weighted, diffusion-
weighted imaging (DWI) and dynamic contrast enhanced imaging (DCE) provide qualitative and 
quantitative information of different tissue types which can be used to construct “tissue” signatures information of 
tissue 1-4.  Therefore, to integrate mpMR and characterize breast tissue, we have developed a machine 
learning method coupled with deep learning for segmentation and characterization of breast tissue using 
mpMRI.  Deep learning networks (DLN) allow for the “learning” of radiological relationships between 
different tissue types and provides new methods to “segment” and/or classify high-dimensional data 
sets5-11. These DLN algorithms allow for accurate and reliable prediction of tissue types from “raw” 
input images with the aim to improve the radiologist’s clinical decision support in different diseases12-
15. Therefore, we implemented an unsupervised deep learning system based on stacked sparse 
autoencoders (SSAE). Autoencoders are unsupervised neural networks that are trained to create a 
compact or a low dimensional representation of its input via the hidden layer 7,9,16,17. The stacked sparse 
autoencoder network (SSAE) is a stack of sparse autoencoders with each autoencoder forming a layer 
of the SSAE. This allows us to use deep learning to develop multiparametric breast tissue signatures 
across subjects, without prior knowledge of the lesion type for application to patients for tissue 
segmentation and classification of breast lesions.   
In this work, we establish the use of a multiparametric deep learning SSAE for radiological 
biomarkers of breast tissue by demonstrating that the MPDL SSAE can segment different breast 
tissue types, i.e., fatty, glandular, and lesion tissue. Second, we can classify the breast lesions into 
benign or malignant and show that the results are similar to radiologists. Finally, we developed and 
validated the MPDL tissue signature model with an independent data set in breast cancer patients. 
 
 
Materials and Methods 
Clinical subjects: All studies were performed in accordance with the institutional guidelines for clinical 
research under a protocol approved by the Johns Hopkins University School of Medicine Institutional 
Review Board (IRB) and all HIPAA agreements were followed for this retrospective study.  One hundred 
and eighty-nine women (96 malignant, 39 benign and four normal (no-lesion) and were scanned. 
Malignancy was determined by pathology in all cases.   Fifty (n=50) cases were obtained from 
University California San Francisco (UCSF) for an independent deidentified test data set.  These fifty 
cases are from a Phase 3 clinical trial for women receiving neoadjuvant chemotherapy for locally 
advanced breast cancer defined by histology18,19. We used the baseline study before initiation of the 
therapeutic regimen.  
 
Multiparametric MRI imaging protocol: MRI scans were performed on a 3T magnet (Philips North 
America Corporation), using a dedicated phased array breast coil with the patient lying prone with the 
breast in a holder to reduce motion. MRI sequences consisted of fat suppressed (FS) T2WI spin echo 
(TR/TE=5700/102) and fast spoiled gradient echo (FSPGR) T1WI (TR/TE =200/4.4, Field of View 
(FOV)=256x256, slice thickness(ST), 4mm, 1mm gap); diffusion-weighted (TR/TE=5000/90ms,b=0- 
800, FOV= 192x192,ST=6mm); and finally, pre- and post-contrast enhanced images FSPGR T1WI 
(TR/TE=20/4, FOV=512x512, ST=3 mm) were obtained after intravenous administration of a GdDTPA 
contrast agent (0.2mL/kg(0.1 mmol/kg)).  The contrast agent was injected over 10 seconds, with MRI 
imaging beginning immediately after completion of the injection and the acquisition of 14 phases.  The 
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contrast bolus was followed by a 20cc saline flush. The DCE protocol included two minutes of high  
temporal resolution (15 sec per 
acquisition) imaging to capture the 
wash-in phase of contrast 
enhancement. A high spatial 
resolution scan for two minutes 
then followed, with additional high 
temporal resolution images (15 
sec per acquisition) for an 
additional two minutes to 
characterize the wash-out slope of 
the kinetic curve for 
pharmacokinetics(PK)2.  Total 
scan time for the entire protocol 
was less than 45 minutes. 
The independent validation breast 
MRI scans were acquired on a 
different 1.5 T magnets using a 
dedicated breast RF coils and 
obtained from the ACRIN I-SPY 
clinical trial18,19. The images used 
for validation were fat suppressed, 
T1 weighted dynamic contrast 
enhanced series obtained 
unilaterally in the sagittal 
orientation with TR≤20ms, 
TE=4.5ms, flip angle≤45°, FOV: 
160-180, matrix size > 256x192, 
ST ≤ 2.5 mm. 
 
 
Multiparametric Image Registration:The mpMRI were coregistered using a hybrid registration 
algorithm that combines 3D wavelet transformation for 3D reslicing and rescaling of the MRI volumes 
with nonlinear affine transformation to minimize the loss of information in image transformations 20. The 
pre-contrast image of the DCE dataset was used as the reference image for all the other MRI images. 
Multiparametric MRI tissue signature generation:The Eigenimage filter (EI) segmentation algorithm 
was used to segment the breast lesions from the post contrast DCE image.  The EI is a linear filter that 
maximizes the projection of a desired tissue (lesion tissue) while it minimizes the projection of undesired 
tissues (glandular tissue) onto a composite image called an Eigenimage 21,22.  Tissue signatures of 
glandular, fatty, and lesion tissue were defined using the EI filter are described below.  Moreover, the 
EI corrects for partial volume effects, this allows for better demarcation of the underlying structures 23.  
Multiparametric Deep Learning Tissue Signatures: The multiparametric deep learning network was 
trained on the breast tissue signatures defined using EI identified on all the original breast MRI images as 
demonstrated in Figure 1. The MPDL network builds a composite feature representation of the breast 
tissue signatures of the underlying breast tissue.A voxel tissue signature vector is defined as the vector of 
gray level intensity values corresponding to that voxel position in each image in the entire data sequence 
(n=23 images).  Mathematically, the MPDL tissue signature is defined as follows:  
  1 2, , ,
T
nMPDLTissue Signature T T DWI DCE  
 
Figure 1. Demonstration of the multiparametric deep learning tissue signatures on 
axial mpMRI of the breast.  Representative tissue signatures from the normal and 
abnormal tissue are obtained on each of the input MRI to create the vector 
signature MPDLij. 
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For this study, four sets of tissue signature vectors were defined. The first set of tissue signatures for 
normal tissue,  1 2, , .
T
nNormal N N N  was chosen from the glandular tissue, second one for fatty 
tissue,  1 2, , .
T
nFatty F F F , a third one for lesion tissue,  1 2, , .
T
nLesion L L L and a fourth one for 
background noise.  Each set of MPDL tissue signature vectors created automatically using a 
multiparametric region growing algorithm. The initialization to the region growing algorithm is provided by 
the operator identifying pixels within the tissue of interest. The tolerance for region growing was set at 5%. 
The final ROI is created by computing a logical AND operation between the ROIs generated from region 
growing on each of the MR images (Figure 1). By using several images concurrently, the probability of a 
pixel from another tissue being included in the final ROI (due to noise, partial volume, and nonuniformities) 
is reduced.  The computer time required for producing the final ROI was less than a second for each tissue 
type. 
Multiparametric Deep Learning Network 
Stacked Sparse Autoencoders Network Architecture: We developed the mpMRI segmentation 
deep network by stacking sparse autoencoders (SSAE) for segmenting a multiparametric breast MRI 
dataset into regions corresponding to different tissue types. 
Figure 2 demonstrates the network architecture of the mpMRI segmentation deep network. Each 
sparse autoencoder of the SSAE was pre-trained in an unsupervised fashion to create a low 
dimensional representation of its input via the hidden layer by the tissue signature vectors. The input 
to each autoencoder except the first autoencoder was the hidden layer representation discovered by 
the previous layer. The first layer autoencoder learns a low dimensional representation, 𝑌 =
{𝑦(1), 𝑦(2), … , 𝑦(𝑁)} ∈ 𝑅𝑑 from the training input tissue signatures, 𝑋 = {𝑥(1), 𝑥(2), … , 𝑥(𝑁)} ∈ 𝑅𝐷, where D 
is the dimensionality of the input tissue signatures, N is the total number of tissue signatures and d is 
the number of nodes in the hidden layer of the autoencoder. The output of the final sparse autoencoder 
was used as input to train a softmax classifier to identify the input tissue signature as background, fat, 
glandular or lesion. 
 
 
 
 
 
 
 
 
 
 
 
 
Multiparametric MRI segmentation deep network training and evaluation: For the MpMRI 
segmentation, the training parameters obtained from optimization were set as follows: the number of 
 
Figure 2. Framework for mpMRI segmentation deep network trained to segment multiparametric breast 
MRI into regions of different tissue types and background. The stacked sparse encoder deep network 
is constructed of ten hidden layers with five nodes each and a softmax classification layer that outputs 
the probability of different tissue types for the input tissue signature. 
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layers=5, the number of nodes in each hidden layer=10, L2 regularization penalty = 0.001, Sparsity 
proportion = 0.5, Sparsity regularization = 4.  The transfer function for the autoencoder nodes was 
selected as the saturating linear function given as  
𝑓(𝑥) =     {
0, 𝑖𝑓 𝑥 ≤ 0         
𝑥, 𝑖𝑓 0 < 𝑥 < 1
1, 𝑖𝑓 𝑥 ≥ 1        
  
We tested the MPDL for segmentation of breast tissue into different tissue classes using a two-fold 
cross validation. The balance between number of tissue signatures used to train different tissue types 
were maintained by sampling uniformly at random equal number of tissue signatures corresponding to 
each tissue type from each patient.  Moreover, the MPDL tissue signature can adapt to the input 
sequences into the SSAE.  
To perform a quantitative comparison between the MPDL segmented regions, we defined the 
radiological ground truth for breast imaging by the EI segmented regions. The dice similarity index (DS) 
was used as the overlap evaluation metric 24. The dice similarity index is designed to find the similarity 
between overlapping regions from two objects.  Mathematically, DS is given by the following equation: 
𝐷𝑆 =
2(𝐴 ∩ 𝐵)
𝑛(𝐴) + 𝑛(𝐵)
 
Here, A and B are the lesion areas obtained by ground truth (EI segmented post-contrast image) and 
the multiparametric deep learned image, respectively. The EI segmentation was obtained by 
thresholding the EI contrast image. The threshold was obtained by evaluating the post-contrast MR 
image histogram, and using the mean and a 95% confidence interval.  
Multiparametric MRI classification deep network training and evaluation: For the MpMRI 
classification, we developed a hybrid feature extraction and classification method termed SAE-SVM by 
combining sparse autoencoder (SAE) with support vector machine (SVM) algorithm. The unsupervised 
SAE component of the SAE-SVM algorithm automatically extracted the intrinsic tissue signatures for 
each MRI parameter which were then trained by the linear SVM classifier to predict a tumor as benign 
or malignant. The training parameters of the SAE were set as follows: Number of nodes in the hidden 
layer=10, L2 regularization penalty=0.001, Sparsity proportion=0.5, Sparsity regularization=4, Encoder 
transfer function: sigmoid, Decoder transfer function: linear. The imbalance in the number of benign 
and malignant patients was resolved by setting a higher misclassification cost for benign than malignant 
patients. The SAE-SVM feature extraction and classification method was tested using leave-one-out 
and ten-fold cross validation with sensitivity, specificity and area under the receiver operating 
characteristic curve (AUC) as the evaluation metrics.  The imbalance in the number of benign and 
malignant patients was resolved by setting a higher misclassification cost for benign than malignant 
patients. The optimal value of the misclassification penalty was obtained using grid search on 
misclassification penalty ratios from the set Benign: Malignant = {1: 1, 1.5: 1, 2: 1, 2.5: 1, 3: 1, 3.5: 1, 4: 1}. 
 
Validation of the Multiparametric Deep Learning Network. 
Magnetic Resonance Imaging Data: We used 50 patients with calculated volumes from the University 
California at San Francisco I-Spy ACRIN study to test our MPDL network18,19.  To compare with our 
dataset, we used the baseline DCE contrast imaging session from the study18,25,26. The UCSF data was 
registered to the pre-contrast DCE image.  After application of the MPDL, the MPDL and UCSF volumes 
were compared and analyzed.  
 
Statistical Methods: We computed summary statistics (mean and standard deviations) from the 
quantitative imaging parameters from the mpMRI.  The percentage difference and overlap segmented 
from the lesion areas were computed and compared.  Statistical analysis was performed using linear 
regression to correlate the total lesion areas. A Student’s t-test was used to determine statistical 
significance between the lesion areas and the percent difference between the lesion boundaries.  Sample 
size was calculated based on the ROC curve by combining information from multiple MRI tissue 
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contrasts 27-29.  A sample size of 112 can give 85% power to detect an increase in specificity (under 
significance level alpha=0.05). 
The same sample size also gives us greater than 85% power to differentiate sensitivities between 80% 
and 95% at alpha=0.05 significance level. We increased our total sample size from 112 to 189.  Bland-
Altman tests were run to insure no bias in the validation data set. Sensitivity and specificity with Area under 
Curve (AUC) was computed. Statistical significance was assigned for p < 0.05.   
 
Results 
Patient Demographics:There were total of 139 women with suspicious breast lesions in this study 
(n=139 training). For the training set (n=139) the mean age was 52 years (range: 24-80 years).  Ninety-
six patients had malignant breast lesions (69%) while thirty-nine patients had benign breast lesions 
(28%) and four had no lesions identified (3%).    
 
Quantitative mpMRI:In the training data set, the DWI and DCE sequences provided quantitative 
radiological metrics. there were significant differences (p<0.001) between the ADC map values for 
malignant and benign breast lesions.  ADC values for malignant cases were (mean and standard 
deviation) 1.26±0.13 (mm2x10-3/s) and benign lesions were 1.74±0.17 (mm2x10-3/s).  Glandular tissue 
ADC values for malignant and benign lesions were not significantly different, 2.16±0.46 and 2.34±0.33 
(mm2x10-3/s), respectively.  The DCE PK values were significantly different (p<0.05) between malignant 
and benign lesions.  The  Ktrans  values were 0.55±0.32 (1/min) and EVF were 0.30±0.16 for malignant 
cases and 0.25±0.19 (1/min)  and 0.22±0.13 for benign cases, respectively. 
 
 
Figure 3.  Illustrates the use of MPDL network on axial breast mpMRI in five representative malignant patients. The color 
coding for different tissue types are shown to the right of the images.  
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Training Data Set:The MPDL tissue signatures were defined for different breast tissue types (Figure 
1) and applied to the 139 mpMRI breast cases.  Figure 2 demonstrates the mpMRI deep network 
segmentation for the tissue signatures.    Figure 3 illustrates the results on five representative malignant 
patients.  Similarly, figure 4 illustrates the mpMRI deep network segmentation results on five benign 
patients. Figures 3 and 4, demonstrate the mpMRI deep network successfully segmented different 
tissue types from benign and malignant patients using the tissue signature model.  The dice similarity 
index between the lesion segmentations demonstrated excellent overlap with mean and standard 
deviation (SD) 0.87±0.05 for malignant patients and 0.85±0.07 for benign patients. Representative 
cases are shown in Figure 5.  The optimal value of misclassification ratio was obtained at 2:1 i.e. benign 
patients had misclassification penalty set twice that of malignant patients. 
Validation Testing: The validation of the MPDL was done on an independent clinical data set 
(University of California-San Francisco-UCSF) was excellent18,19.  Figure 6 illustrates representative 
cases comparing the segmented tissue regions of the UCSF validation data set using the MPDL tissue 
signatures.  The lesion volumes defined by MPDL and USCF resulted in a small percent difference of 
4.4%±3.9%.  Bland-Altman plots are shown in Figure 7, demonstrating no bias and excellent 
agreement between the data set. Finally, the sensitivity and specificity for differentiation of malignant 
from benign lesions were 90% and 85% respectively with an AUC of 0.93 and shown in Figure 8. 
 
 
Discussion  
Utilizing multiparametric deep learning network, we have developed, tested, and validated a cognitive 
computing platform that organizes, integrates, and interprets imaging information using a MPDL tissue 
signature model.  The application of the MPDL tissue signature model resulted in excellent 
segmentation and classification of different tissue classes. This study employed an integrated 
 
Figure 4.  Illustrates the use of MPDL network on axial breast mpMRI in five representative benign patients. The color 
coding for different tissue types are shown to the right of the images.   
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multiparametric breast MRI deep learning model in the clinical setting and demonstrates that MPDL 
tissue signatures defines benign and malignant tissue and performs accurate classification. Moreover, 
this report demonstrates that deep learning-assisted unsupervised segmentation using mpMRI 
signatures can detect heterogeneous zones within breast lesions. These heterogeneous regions can 
be used for further classification of breast tissue by quantitative ADC maps and/or PK-DCE parameters.  
Finally, the MPDL model with machine learning classification distinguished between benign and 
malignant tissue with high sensitivity, specificity, and accuracy.   
 The results from application of MPDL tissue signature model to an independent breast MRI 
dataset demonstrated the robustness of the MPDL model.  Importantly, the MPDL model was able to 
accurately segment breast tissue irrespective of the magnetic field strength (3T for our data and 1.5T 
for the validation set). Furthermore, the MPDL model was invariant to the imaging orientation as our 
dataset was in the axial plane while the validation set was obtained in sagittal plane. This invariance is 
due to the underlying depiction of the tissue using tissue signature vectors, which captures the tissue 
underlying characteristics and allows for the “adjustment” to different MRI input. Moreover, the MRI 
parameters, as well as, the time resolution of the DCE image phases used to train the MPDL model 
were different for our dataset and the validation dataset reasserting the robust nature of the MPDL 
model and eliminates the need to “retrain” the MPDL model.  
The mpMRI parameters used in this 
study were based on our and others 
previous results in patients 1,3,4,30.   
These studies demonstrated that 
the combined MRI sequences 
consisting of DWI, ADC, and PK-
DCE were highly correlated with the 
histological phenotype of the tissue.  
The sensitivity and specificity of 
classification between malignant 
and benign tumors by MPDL were 
similar to radiologists 31,32.  This is 
very encouraging when the future 
reading rooms will have advanced 
computing power to assist in 
reading of cases.  Currently, it is 
very unlikely that machine learning 
and deep learning will replace 
radiologists as has been suggested 
by some, yet there may be a role for 
improved efficiency in the workflow 
and accuracy of interpretation. 
Using advanced computational 
methods with allow for this coming change to be better managed within radiology.  Our results 
demonstrate that the MPDL method can be used on an independent data set acquired from different 
institutions. Indeed, the I-Spy trial is one of the largest MRI trials and incorporates many different MRI 
field strengths.  However, the ability for the MPDL to learn different tissue signatures allows it to adapt 
to different data sets with highly accurate results.  This was shown with the high dice similarity of the 
validation data using different input MRI data.  
 
Figure 5.  Demonstration of dice similarity overlap between the Eigenimage and MPDL 
segmentation masks of two benign (A and B) and two malignant (C and D) patients 
overlaid on the subtracted dynamic contrast enhanced image. The Eigenfilter 
segmentation boundary is shown in yellow and the MPDL segmentation boundary is 
displayed in red. On the overlap masks, the blue region corresponds to the overlap 
between the two methods, red represents the area segmented by the MPDL alone 
while yellow represents the area segmented by Eigenfilter alone.  
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There are, however, some technical 
limitations to the use the MPDL network in 
practice.  First, increased computational 
power on the graphical processor units 
((GPU) > 2500 cores, 12GB)) used here 
may not be widely available.  However, the 
use of advanced GPU computing is rapidly 
finding applications in many different 
radiological datasets10,12,15,33-36. More 
specific to the present study, any 
assessment of the clinical value of MPDL 
network will require additional studies in a 
larger patient population.   Moreover, a 
prospective trial with subsequent follow-up 
and pathological correlation using MPDL 
will provide us with new data to explore the 
exact application and methods to apply to 
larger studies.     
In conclusion, we have demonstrated that 
integrated MPDL method accurately 
segmented and classified different breast tissue from multiparametric breast MRI. The MPDL images 
allow for improved visualization of different tissue characteristics based on multiple radiological 
parameters.   
 
 
Figure 6. Demonstration of three representative sagittal breast cases from the validation cohort and the resulting 
MPDL segmentations.  In all cases the segmented regions of breast lesions were highly correlated between each other. 
The color coding for different tissue types are shown to the right of the images. 
 
Figure 7. Bland-Altman plots demonstrating the limits of 
agreement of the percent differences from the validation data set 
and MPDL segmentations.  The mean is shown by the center line 
and the confidential intervals (±2SD) are shown at 10.6% and -
12.9%. the resulting.  The plot shows excellent agreement 
between the two measurements.  
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Appendix 
The MPDL framework is based autoencoders as shown in figure 2. An autoencoder has two parts: an 
encoder and a decoder.  The encoder maps the vector X to the vector h(1) representing the hidden layer 
as follows: 
𝒉(𝟏) = 𝒇 (𝑾𝑿 + 𝒃) 
 where f is the transfer function for the encoder, 𝑊 ∈ 𝑅𝑑×𝐷 is the matrix of weights and b is the bias 
vector.  
Where the decoder maps h(1) back to X using the following equation: 
?̂? = 𝒈(𝑾′𝒉(𝟏) + 𝒃′) 
The values of W’ and b’ are equal to the transpose of W and b in case the weights are tied between 
encoder and decoder.  The network comprises of layers and nodes within each layer. The nodes in the 
hidden layer were further specialized to activate in response to only a subset of the total number of 
MPDL tissue signatures using sparsity regularization. For example, after training the sparse 
autoencoder on a mpMRI dataset, node 1 may have “specialized” in activating only in response to a 
fatty tissue signature while node 2 may have “specialized” in activating only in response to a glandular 
tissue signature. Mathematically, the average activation, 𝜌?̂?  of a neuron, j is given by the following 
equation 
𝝆?̂? =
𝟏
𝑵
∑ 𝒉𝒋
(𝟏)(𝒙𝒊)
𝑵
𝒊=𝟏
 
where N is the total number of training samples. If 𝜌 denotes the desired average activation or the 
sparsity proportion of the neuron, j across all the training samples, our goal is to impose the constraint 
𝜌?̂? = 𝜌. Consequently, the sparsity regularization term added to the cost function is given as  
 
Figure 8.  The receiver operating characteristic curve 
from the MPDL classification shows an AUC=0.93 with 
a sensitivity of 90% and specificity of 85%. 
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𝑹𝑺 = 𝛃 ∑ (𝝆 𝐥𝐨𝐠 ?̂?𝒋 + (𝟏 − 𝝆) 𝐥𝐨𝐠
𝟏 − 𝝆
𝟏 − ?̂?𝒋 
)
𝒅
𝒋=𝟏
 
 where 𝛽 is the sparsity regularization penalty.  Because we have four tissue classes, the sparsity 
proportion, 𝜌 was set at 0.25 and the penalty, β was set at 4 to train each sparse autoencoder. 
The output of the final sparse autoencoder was used as input to train a softmax classifier to classify the 
tissue signatures as background, fat, glandular or lesion. The cost function for training the softmax layer 
of the mp MRI segmentation deep network was based on cross entropy, given by 
𝑱 =
𝟏
𝑵
∑ ∑ 𝒕𝒊𝒋 𝐥𝐧 𝒚𝒊𝒋 + (𝟏 − 𝒕𝒊𝒋) 𝐥𝐧(𝟏 − 𝒚𝒊𝒋)
𝟒
𝒋=𝟏
𝑵
𝒊=𝟏
 
where tij is the target class and yij is the output of the deep network at the softmax classification layer. 
The weights of the pre-trained network were further fine-tuned using scaled conjugate gradient 
backpropagation method to improve the classification accuracy of the pre-trained network. The pre-
trained weights are especially useful when the application is limited by the number of available training 
examples. After training, the first layer of the SSAE learns the most representative tissue signatures 
from the input dataset while the stack of subsequent autoencoders forms a composite representation 
of the tissue signatures, such that each node of the final layer specializes in recognizing tissue 
signatures from a single tissue type.  
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Figures 
 
Figure 1. Demonstration of the multiparametric deep learning tissue signatures on axial mpMRI of the 
breast.  Representative tissue signatures from the normal and abnormal tissue are obtained on each 
of the input MRI to create the vector signature MPDLij.  
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Figure 2. Framework for mpMRI segmentation deep network trained to segment multiparametric breast 
MRI into regions of different tissue types and background. The stacked sparse encoder deep network 
is constructed of ten hidden layers with five nodes each and a softmax classification layer that outputs 
the probability of different tissue types for the input tissue signature. 
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Figure 3.  Illustrates the use of MPDL network on axial breast mpMRI in five representative malignant 
patients. The color coding for different tissue types are shown to the right of the images.   
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Figure 4.  Illustrates the use of MPDL network on axial breast mpMRI in five representative benign 
patients. The color coding for different tissue types are shown to the right of the images.   
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Figure 5.  Demonstration of dice similarity overlap between Eigenimage and MPDL segmentation 
masks of two benign (A and B) and two malignant (C and D) patients overlaid on the subtracted 
dynamic contrast enhanced image. The Eigenfilter segmentation boundary is shown in yellow and the 
MPDL segmentation boundary is displayed in red. On the overlap masks, the blue region 
corresponds to the overlap between the two methods, red represents the area segmented by the 
MPDL alone while yellow represents the area segmented by Eigenfilter alone.   
 
20 
 
 
Figure 6. Demonstration of three representative sagittal breast cases from the validation cohort and 
the resulting MPDL segmentations.  In all cases the segmented regions of breast lesions were highly 
correlated between each other. The color coding for different tissue types are shown to the right of 
the images. 
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Figure 7. Bland-Altman plots demonstrating the limits of agreement of the percent differences on the 
representative sagittal breast cases from the validation data set and MPDL segmentations.  The mean 
is shown by the center line and the confidential intervals (±2SD) are shown at 10.6% and -12.9%. the 
resulting.  The plot shows excellent agreement between the two measurements.  
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Figure 8. The receiver operating characteristic curve from the MPDL classification shows an AUC=0.93 
with a sensitivity of 90% and specificity of 85%. 
 
 
 
 
